医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Advanced Sterilization Products on Preventing the Spread of Coronavirus from Contaminated Medical Devices

2020年02月07日 AM07:52
このエントリーをはてなブックマークに追加


 

IRVINE, Calif.

Advanced Sterilization Products (ASP) released today an interview with experts Ryan Lewis, M.D., Senior Director of Medical Affairs and Medical Safety, and Jeremy Yarwood, Vice President of Research and Development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200206006009/en/

Advanced Sterilization Products on Preventing the Spread of Coronavirus from Contaminated Medical Devices (Photo: Business Wire)

Advanced Sterilization Products on Preventing the Spread of Coronavirus from Contaminated Medical Devices (Photo: Business Wire)

On January 30, 2020 the World Health Organization (WHO) declared the recent outbreak of novel coronavirus a global emergency.* This measure, taken only five times in the history of the WHO, occurs when an extraordinary event is determined to constitute a public health risk through the international spread of disease. As suspected and confirmed cases grow in China and around the world, healthcare professionals globally are reviewing their risk management programs to ensure readiness for a potentially-serious, rapid contagion.

“Devices such as bronchoscopes, ENT flexible endoscopes and laryngoscopes are used for the diagnosis and treatment of patients with advanced coronavirus infections,” remarked Ryan Lewis, M.D. “These devices are reusable and must be disinfected or sterilized between uses. A high number of patients needing advanced care for coronavirus could result in a single device being used multiple times a day.”

Jeremy Yarwood gave details on how healthcare professionals process medical equipment that has been exposed to coronavirus in order to protect patients and staff, and noted how his company is working to help healthcare officials who are dealing with this contagion. “ASP is actively working with regulators and healthcare providers across the world and specifically in China to provide products that can aid reducing or preventing the spread of infection.”

To read the full interview with these ASP experts, visit www.asp.com/preventing-the-spread-of-coronavirus-from-contaminated-medical-devices.

*World Health Organization. (2019, January 30). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) [Press release]. Retrieved from https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)

ABOUT ADVANCED STERILIZATION PRODUCTS (ASP)

Advanced Sterilization Products (ASP) has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health care and safety for those who matter most. Our pioneering technology, global distribution and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day for thousands of medical facilities around the world. This enables our customers to focus on what they do best – preventing infection and saving lives. For more information, please visit www.ASP.com.

©ASP 2019. All rights reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200206006009/en/

CONTACT

Advanced Sterilization Products

Mandy Allen

Director, Commercial Marketing

ASP-media@asp.com

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024